Director – Global Forecasting
Revolution Medicines
Director – Global Forecasting
Revolution Medicines
Clinical-stage oncology company developing RAS inhibitors
Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio of oral RAS(ON) inhibitors designed to directly target the active, cancer-driving state of RAS. Founded on rigorous scientific inquiry and a willingness to challenge long-held assumptions, Revolution Medicines is committed to changing the trajectory of disease for patients with RAS-addicted cancers worldwide.
Our people are united by a shared way of working: follow the science, challenge assumptions, act with urgency and hold ourselves to a high standard of rigor—all in service of patients.
The Opportunity:
Reporting directly to the Sr. Director, Global Analytics and Insights, the Director, Global Forecasting role requires strategic thinking and expertise to provide critical contributions to disease area strategy, life-cycle planning and product and portfolio decisions. This role involves developing, refining, and communicating key strategic and revenue forecast assumptions and analyses to inform and support decision-making across the organization. This role will also work directly with Regional Forecasting leads to ensure consistency in forecast approach, assumptions, and analyses. The ideal candidate will have experience working on pipeline molecules in Oncology, strong problem-solving skills, a strategic mindset, and will exhibit curiosity, flexibility, and be comfortable with ambiguity.
This position would ideally be based at our headquarters in Redwood City, CA., however open to remote candidates who are willing to travel to our CA office on a regular basis.
Responsibilities include:
Develops and maintains long-term forecast models and scenario plans for RevMed’s products across indications.
Provides portfolio level views and analyses to support organizational decision making via streamline models and consolidation processes.
Communicates and aligns key internal stakeholders around key forecast assumptions.
Understands complex markets, disease states, competitive landscapes, and relevant market and managed care dynamics and uses this knowledge to develop strategic forecasts and plans.
Synthesizes and communicates the similarities, differences, and considerations necessary to inform Global clinical development plans.
Exhibits analytical rigor in the valuation of business opportunities and the quantification of risk.
Participates in cross-functional teams to gather input for functional activities, and ensure alignment.
Partners closely with other Insights and Analytics functions (Market Research, Data Analytics, Competitive Intelligence) to inform the forecast.
Works closely with Pipeline Marketing, Clinical Development, Portfolio Management, and Medical Affairs to support early-stage decision making.
Works closely with Regional forecasting leads to ensure consistency and understand differences in forecasts.
Maintains an in-depth understanding of Revolution Medicines’ diverse product offerings, competitive positioning, and the broader market dynamics shaping the industry's future.
Collaborates with vendor partners to manage various deliverables and analyses.
Required Skills, Experience and Education:
Bachelor's degree required (MBA preferred) with 10+ years of progressive experience in a pharmaceutical, biotechnology, or strategic consulting role with 6+ years of experience in a related analytics/forecasting role.
Experience developing long-range patient-based forecasts for oncology products.
Experience supporting pipeline and portfolio decision making and supporting executional strategy for pipeline analytics and insights.
Track record of being a collaborative team player, and adaptive to meet the needs of a growing business.
Strong problem solver with experience leveraging a variety of research and analytical vendors, study designs, and building quality research vendor partnerships.
Demonstrated ability to influence senior management and key business partners.
Proven experience in a smaller, rapidly growing, company.
Excellent organizational skills and an ability to prioritize effectively to deliver results within reasonably established timelines.
Ability to represent Revolution Medicines well: strong interpersonal skills including verbal and written communication.
Entrepreneurial mindset, with a tolerance for ambiguity, and a passion for helping cancer patients.
Preferred Skills:
8+ years of experience in patient-based forecasting with focus in Oncology.
Experience with targeted oncolytics.
Experience working with Global teams.
Demonstrated ability to synthesize complex information and influence decision-making at the executive level.
#LI-JW1 #LI-Remote
The base pay salary range for this full-time position for candidates working onsite at our headquarters in Redwood City, CA is listed below. The range displayed on each job posting is intended to be the base pay salary range for an individual working onsite in Redwood City and will be adjusted for the local market a candidate is based in. Our base pay salary ranges are determined by role, level, and location. Individual base pay salary is determined by multiple factors, including job-related skills, experience, market dynamics, and relevant education or training.
Please note that base pay salary range is one part of the overall total rewards program at RevMed, which includes competitive cash compensation, robust equity awards, strong benefits, and significant learning and development opportunities.
Revolution Medicines is an equal opportunity employer and prohibits unlawful discrimination based on race, color, religion, gender, sexual orientation, gender identity/expression, national origin/ancestry, age, disability, marital status, medical condition, and veteran status.
Revolution Medicines takes protection and security of personal data very seriously and respects your right to privacy while using our website and when contacting us by email or phone. We will only collect, process and use any personal data that you provide to us in accordance with our CCPA Notice and Privacy Policy. For additional information, please contact [email protected].
We are aware of recent recruitment scams in which individuals or organizations falsely represent themselves as being affiliated with Revolution Medicines. These scams may appear as false job advertisements or unsolicited contacts through communication or chat platforms, email, phone, or text message.
Please note that Revolution Medicines does not extend unsolicited employment offers and will never ask candidates to provide financial information, purchase equipment, or pay fees as part of the hiring process. All legitimate communication from Revolution Medicines will come from an official @revmed.com email address.
If you believe you’ve been contacted by someone impersonating a Revolution Medicines recruiter, please report it to [email protected] so we can share these impersonations with our IT team for tracking and awareness.
Base Pay Salary Range 201000 - 251000 USD
Clinical-stage oncology company developing RAS inhibitors
Revolution Medicines develops precision oncology drugs focused on cancers driven by RAS mutations. Its RAS(ON) inhibitors are small molecules that bind the active form of RAS to block cancer signaling, with candidates like Daraxonrasib (RMC-6236), Elironrasib (RMC-6291), and Zoldonrasib (RMC-9805) advancing in global Phase 3 trials. The company funds its research through collaborations, royalties, and upfront funding, and has not yet marketed a product. Its goal is to bring effective RAS-targeted therapies to patients and advance multiple candidates through late-stage trials toward approval, supported by strong cash reserves.
Explore more opportunities at Revolution Medicines